List of Tables
Table 1. Global Active Pharmaceutical Ingredients CDMO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Traditional Active Pharmaceutical Ingredient (Traditional API)
Table 3. Key Players of Highly Potent Active Pharmaceutical Ingredient (HP-API)
Table 4. Key Players of Antibody Drug Conjugate (ADC)
Table 5. Key Players of Others
Table 6. Global Active Pharmaceutical Ingredients CDMO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Active Pharmaceutical Ingredients CDMO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Active Pharmaceutical Ingredients CDMO Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Active Pharmaceutical Ingredients CDMO Market Share by Region (2019-2024)
Table 10. Global Active Pharmaceutical Ingredients CDMO Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Active Pharmaceutical Ingredients CDMO Market Share by Region (2025-2030)
Table 12. Active Pharmaceutical Ingredients CDMO Market Trends
Table 13. Active Pharmaceutical Ingredients CDMO Market Drivers
Table 14. Active Pharmaceutical Ingredients CDMO Market Challenges
Table 15. Active Pharmaceutical Ingredients CDMO Market Restraints
Table 16. Global Active Pharmaceutical Ingredients CDMO Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Active Pharmaceutical Ingredients CDMO Market Share by Players (2019-2024)
Table 18. Global Top Active Pharmaceutical Ingredients CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredients CDMO as of 2023)
Table 19. Ranking of Global Top Active Pharmaceutical Ingredients CDMO Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Active Pharmaceutical Ingredients CDMO Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Active Pharmaceutical Ingredients CDMO Product Solution and Service
Table 23. Date of Enter into Active Pharmaceutical Ingredients CDMO Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Active Pharmaceutical Ingredients CDMO Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Active Pharmaceutical Ingredients CDMO Revenue Market Share by Type (2019-2024)
Table 27. Global Active Pharmaceutical Ingredients CDMO Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Active Pharmaceutical Ingredients CDMO Revenue Market Share by Type (2025-2030)
Table 29. Global Active Pharmaceutical Ingredients CDMO Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Active Pharmaceutical Ingredients CDMO Revenue Market Share by Application (2019-2024)
Table 31. Global Active Pharmaceutical Ingredients CDMO Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Active Pharmaceutical Ingredients CDMO Revenue Market Share by Application (2025-2030)
Table 33. North America Active Pharmaceutical Ingredients CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Active Pharmaceutical Ingredients CDMO Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Active Pharmaceutical Ingredients CDMO Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Active Pharmaceutical Ingredients CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Active Pharmaceutical Ingredients CDMO Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Active Pharmaceutical Ingredients CDMO Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Active Pharmaceutical Ingredients CDMO Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Active Pharmaceutical Ingredients CDMO Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Active Pharmaceutical Ingredients CDMO Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Active Pharmaceutical Ingredients CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Active Pharmaceutical Ingredients CDMO Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Active Pharmaceutical Ingredients CDMO Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size by Country (2025-2030) & (US$ Million)
Table 48. Cambrex Company Detail
Table 49. Cambrex Business Overview
Table 50. Cambrex Active Pharmaceutical Ingredients CDMO Product
Table 51. Cambrex Revenue in Active Pharmaceutical Ingredients CDMO Business (2019-2024) & (US$ Million)
Table 52. Cambrex Recent Development
Table 53. Recipharm Company Detail
Table 54. Recipharm Business Overview
Table 55. Recipharm Active Pharmaceutical Ingredients CDMO Product
Table 56. Recipharm Revenue in Active Pharmaceutical Ingredients CDMO Business (2019-2024) & (US$ Million)
Table 57. Recipharm Recent Development
Table 58. Thermo Fisher Pantheon Company Detail
Table 59. Thermo Fisher Pantheon Business Overview
Table 60. Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Product
Table 61. Thermo Fisher Pantheon Revenue in Active Pharmaceutical Ingredients CDMO Business (2019-2024) & (US$ Million)
Table 62. Thermo Fisher Pantheon Recent Development
Table 63. Corden Pharma Company Detail
Table 64. Corden Pharma Business Overview
Table 65. Corden Pharma Active Pharmaceutical Ingredients CDMO Product
Table 66. Corden Pharma Revenue in Active Pharmaceutical Ingredients CDMO Business (2019-2024) & (US$ Million)
Table 67. Corden Pharma Recent Development
Table 68. Samsung Biologics Company Detail
Table 69. Samsung Biologics Business Overview
Table 70. Samsung Biologics Active Pharmaceutical Ingredients CDMO Product
Table 71. Samsung Biologics Revenue in Active Pharmaceutical Ingredients CDMO Business (2019-2024) & (US$ Million)
Table 72. Samsung Biologics Recent Development
Table 73. Lonza Company Detail
Table 74. Lonza Business Overview
Table 75. Lonza Active Pharmaceutical Ingredients CDMO Product
Table 76. Lonza Revenue in Active Pharmaceutical Ingredients CDMO Business (2019-2024) & (US$ Million)
Table 77. Lonza Recent Development
Table 78. Catalent Company Detail
Table 79. Catalent Business Overview
Table 80. Catalent Active Pharmaceutical Ingredients CDMO Product
Table 81. Catalent Revenue in Active Pharmaceutical Ingredients CDMO Business (2019-2024) & (US$ Million)
Table 82. Catalent Recent Development
Table 83. Siegfried Company Detail
Table 84. Siegfried Business Overview
Table 85. Siegfried Active Pharmaceutical Ingredients CDMO Product
Table 86. Siegfried Revenue in Active Pharmaceutical Ingredients CDMO Business (2019-2024) & (US$ Million)
Table 87. Siegfried Recent Development
Table 88. Piramal Pharma Solutions Company Detail
Table 89. Piramal Pharma Solutions Business Overview
Table 90. Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Product
Table 91. Piramal Pharma Solutions Revenue in Active Pharmaceutical Ingredients CDMO Business (2019-2024) & (US$ Million)
Table 92. Piramal Pharma Solutions Recent Development
Table 93. Boehringer Ingelheim Company Detail
Table 94. Boehringer Ingelheim Business Overview
Table 95. Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Product
Table 96. Boehringer Ingelheim Revenue in Active Pharmaceutical Ingredients CDMO Business (2019-2024) & (US$ Million)
Table 97. Boehringer Ingelheim Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Active Pharmaceutical Ingredients CDMO Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Active Pharmaceutical Ingredients CDMO Market Share by Type: 2023 VS 2030
Figure 3. Traditional Active Pharmaceutical Ingredient (Traditional API) Features
Figure 4. Highly Potent Active Pharmaceutical Ingredient (HP-API) Features
Figure 5. Antibody Drug Conjugate (ADC) Features
Figure 6. Others Features
Figure 7. Global Active Pharmaceutical Ingredients CDMO Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Active Pharmaceutical Ingredients CDMO Market Share by Application: 2023 VS 2030
Figure 9. Oncology Case Studies
Figure 10. Hormonal Case Studies
Figure 11. Glaucoma Case Studies
Figure 12. Cardiovascular Case Studies
Figure 13. Diabetes Case Studies
Figure 14. Others Case Studies
Figure 15. Active Pharmaceutical Ingredients CDMO Report Years Considered
Figure 16. Global Active Pharmaceutical Ingredients CDMO Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Active Pharmaceutical Ingredients CDMO Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Active Pharmaceutical Ingredients CDMO Market Share by Region: 2023 VS 2030
Figure 19. Global Active Pharmaceutical Ingredients CDMO Market Share by Players in 2023
Figure 20. Global Top Active Pharmaceutical Ingredients CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredients CDMO as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Active Pharmaceutical Ingredients CDMO Revenue in 2023
Figure 22. North America Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Active Pharmaceutical Ingredients CDMO Market Share by Country (2019-2030)
Figure 24. United States Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Active Pharmaceutical Ingredients CDMO Market Share by Country (2019-2030)
Figure 28. Germany Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Active Pharmaceutical Ingredients CDMO Market Share by Region (2019-2030)
Figure 36. China Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Active Pharmaceutical Ingredients CDMO Market Share by Country (2019-2030)
Figure 44. Mexico Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Share by Country (2019-2030)
Figure 48. Turkey Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Cambrex Revenue Growth Rate in Active Pharmaceutical Ingredients CDMO Business (2019-2024)
Figure 51. Recipharm Revenue Growth Rate in Active Pharmaceutical Ingredients CDMO Business (2019-2024)
Figure 52. Thermo Fisher Pantheon Revenue Growth Rate in Active Pharmaceutical Ingredients CDMO Business (2019-2024)
Figure 53. Corden Pharma Revenue Growth Rate in Active Pharmaceutical Ingredients CDMO Business (2019-2024)
Figure 54. Samsung Biologics Revenue Growth Rate in Active Pharmaceutical Ingredients CDMO Business (2019-2024)
Figure 55. Lonza Revenue Growth Rate in Active Pharmaceutical Ingredients CDMO Business (2019-2024)
Figure 56. Catalent Revenue Growth Rate in Active Pharmaceutical Ingredients CDMO Business (2019-2024)
Figure 57. Siegfried Revenue Growth Rate in Active Pharmaceutical Ingredients CDMO Business (2019-2024)
Figure 58. Piramal Pharma Solutions Revenue Growth Rate in Active Pharmaceutical Ingredients CDMO Business (2019-2024)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Active Pharmaceutical Ingredients CDMO Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed